Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.

Allergy immunotherapy across the life cycle to promote active and healthy ageing : From research to policies / M.A. Calderon, P. Demoly, T. Casale, C.A. Akdis, C. Bachert, M. Bewick, B.M. Bilò, B. Bohle, S. Bonini, A. Bush, D.P. Caimmi, G.W. Canonica, V. Cardona, A.M. Chiriac, L. Cox, A. Custovic, F. De Blay, P. Devillier, A. Didier, G. Di Lorenzo, G. Du Toit, S.R. Durham, P. Eng, A. Fiocchi, A.T. Fox, R..G. Van Wijk, R.M. Gomez, T. Haathela, S. Halken, P.W. Hellings, L. Jacobsen, J. Just, L.K. Tanno, J. Kleine-Tebbe, L. Klimek, E.F. Knol, P. Kuna, D.E. Larenas-Linnemann, A. Linneberg, M. Matricardi, H.J. Malling, R. Moesges, J. Mullol, A. Muraro, N. Papadopoulos, G. Passalacqua, E. Pastorello, O. Pfaar, D. Price, P..R. Del Rio, R. Ruëff, B. Samolinski, G.K. Scadding, G. Senti, M.H. Shamji, A. Sheikh, J.C. Sisul, D. Sole, G.J. Sturm, A. Tabar, R. Van Ree, M.T. Ventura, C. Vidal, E.M. Varga, M. Worm, T. Zuberbier, J. Bousquet. - In: CLINICAL AND TRANSLATIONAL ALLERGY. - ISSN 2045-7022. - 6:1(2016 Nov 23).

Allergy immunotherapy across the life cycle to promote active and healthy ageing : From research to policies

E. Pastorello;
2016-11-23

Abstract

Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
ageing; AIRWAYS ICPs; allergen immunotherapy; asthma; EIP on AHA; rhinitis; immunology and allergy
Settore MED/09 - Medicina Interna
CLINICAL AND TRANSLATIONAL ALLERGY
Article (author)
File in questo prodotto:
File Dimensione Formato  
CalderonEtAlii_ClinicalTranslationalAllergy_AllergyImmunotherapy_2016.pdf

accesso aperto

1.19 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/472170
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact